asparagine has been researched along with Parkinson Disease in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.76) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 10 (47.62) | 29.6817 |
2010's | 7 (33.33) | 24.3611 |
2020's | 2 (9.52) | 2.80 |
Authors | Studies |
---|---|
Cao, W; Guo, X; Han, JJ; Hou, H; Lang, M; Li, X; Song, M; Tan, X; Wang, H; Wang, W; Wang, Y; Zhu, Y | 1 |
Li, R; Shi, W; Yan, Z; Yao, L | 1 |
Ahn, EH; Benskey, MJ; Duong, DM; He, L; Iuvone, PM; Jin, L; Kang, SS; Liu, X; Manfredsson, FP; Seyfried, NT; Sun, YE; Wang, JZ; Ye, K; Zhang, Z | 1 |
Bueno-Gil, G; Dávila, JC; Espadas, I; Fuentes, JM; García-Sanz, P; González-Polo, RA; Gutierrez, A; Kulisevsky, J; Mir, P; Moratalla, R; Orgaz, L; Rodríguez-Traver, E; Vicario, C | 1 |
Bardien, S; Carr, J; Keyser, R; Lombard, D; Yako, Y | 1 |
Auff, E; Balzar, J; Brücke, T; Daniel, G; Edris, S; El Tawil, S; Foki, T; Gasser, T; Haubenberger, D; Katzenschlager, R; Lichtner, P; Pirker, W; Reinthaler, E; Schulte, C; Zimprich, A | 1 |
Aasly, JO; Cobb, SA; Dachsel, JC; Farrer, MJ; Felic, A; Haugarvoll, K; Johansen, KK; Kachergus, JM; Lincoln, SJ; Nutt, JG; Payami, H; Ross, OA; Soto-Ortolaza, AI; Toft, M; Vilariño-Güell, C; Webber, PJ; West, AB; White, LR; Wider, C | 1 |
Cobb, SA; Englund, E; Farrer, MJ; Kachergus, JM; Lincoln, SJ; Nilsson, C; Puschmann, A; Rehncrona, S; Ross, OA; Törnqvist, AL; Vilariño-Güell, C; Widner, H; Wszolek, ZK | 1 |
Cao, L; Chen, S; Chen, SD; Liu, J; Ma, JF; Rong, TY; Wang, G; Wang, Y; Xiao, Q; Zhang, Y | 1 |
Ando, M; Funayama, M; Hashimoto, T; Hatano, T; Hattori, N; Ishizu, N; Kashihara, K; Kokubo, Y; Kuzuhara, S; Li, Y; Murakami, Y; Nakano, N; Noguchi, K; Ogaki, K; Sasaki, R; Tomiyama, H; Toyoda, C; Yamashita, C; Yoshino, H | 1 |
Burgunder, J; Cao, B; Chen, K; Chen, X; Chen, Y; Guo, X; Huang, R; Li, J; Shang, HF; Song, W; Zhao, B | 1 |
Oliva, R; Pastor, P | 1 |
Albanese, A; Bracco, F; Di Fede, G; Gasparoli, E; Pasquali, C; Rossi, G; Tagliavini, F; Testa, D | 1 |
Aasly, JO; Farrer, MJ; Pielsticker, L; Ross, OA; Toft, M | 1 |
Eblan, MJ; Giasson, BI; Goker-Alpan, O; Hurtig, HI; Lee, VM; Nguyen, J; Sidransky, E; Trojanowski, JQ | 1 |
Auff, E; Bancher, C; Bonelli, S; Brücke, T; Djamshidian, A; Gasser, T; Grossmann, J; Haubenberger, D; Hotzy, C; Katzenschlager, R; Leitner, P; Lichtner, P; Meitinger, T; Ransmayr, G; Samal, D; Steffelbauer, M; Strom, TM; Zimprich, A | 1 |
Annesi, F; Annesi, G; Carrideo, S; Cirò Candiano, IC; Civitelli, D; Condino, F; De Marco, EV; Messina, D; Morelli, M; Nicoletti, G; Novellino, F; Provenzano, G; Quattrone, A; Rocca, FE; Tarantino, P | 1 |
Bird, TD; Griffith, A; Leis, BC; Leverenz, JB; Mata, IF; Roberts, JW; Samii, A; Schellenberg, GD; Schneer, SH; Sidransky, E; Tsuang, D; Zabetian, CP | 1 |
Bock, H; Hilbig, A; Jardim, LB; Michelin-Tirelli, K; Rieder, CR; Saraiva-Pereira, ML; Socal, MP | 1 |
Arenas, J; Benito-León, J; Cisneros, E; Gasalla, T; Gómez, P; Jiménez-Jiménez, FJ; Molina, JA; Navarro, JA; Ortí-Pareja, M; Vargas, C | 1 |
Diemath, HE; Enge, S; Lechner, H | 1 |
21 other study(ies) available for asparagine and Parkinson Disease
Article | Year |
---|---|
Heritability Enrichment of Immunoglobulin G N-Glycosylation in Specific Tissues.
Topics: Asparagine; Gene Expression Profiling; Genetic Loci; Genome-Wide Association Study; Genotype; Glycosylation; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Linkage Disequilibrium; Lupus Erythematosus, Systemic; Organ Specificity; Parkinson Disease; Phenotype; Polymorphism, Single Nucleotide; Polysaccharides; Quantitative Trait Loci | 2021 |
Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson's Disease.
Topics: Alanine; Animals; Asparagine; Gastrointestinal Microbiome; Glutamine; Hydroxyproline; Methionine; Mice; Parkinson Disease; Rotenone; Serine; Threonine | 2022 |
Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease.
Topics: alpha-Synuclein; Animals; Asparagine; Cysteine Endopeptidases; Disease Models, Animal; Humans; Mice; Parkinson Disease; Protein Aggregation, Pathological; Proteins; Proteolysis | 2017 |
N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
Topics: Asparagine; Autophagy; Beclin-1; Calnexin; Cholesterol; Endoplasmic Reticulum; Female; Fibroblasts; Glucosylceramidase; Golgi Apparatus; Humans; Lysosomal-Associated Membrane Protein 1; Lysosomes; Male; Models, Biological; Mutation; Oxidative Stress; Parkinson Disease; Serine; TOR Serine-Threonine Kinases; Transcription Factor CHOP | 2017 |
Molecular analysis of the parkin gene in South African patients diagnosed with Parkinson's disease.
Topics: Adolescent; Adult; Aged; Arginine; Asparagine; Aspartic Acid; Cysteine; DNA Mutational Analysis; Exons; Female; Gene Frequency; Heterozygote; Humans; Male; Middle Aged; Parkinson Disease; Point Mutation; Sequence Deletion; South Africa; Ubiquitin-Protein Ligases; Young Adult | 2009 |
PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.
Topics: Aged; Asparagine; Austria; Carrier Proteins; DNA Mutational Analysis; Egypt; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Germany; Humans; Male; Middle Aged; Parkinson Disease; Polymorphism, Single Nucleotide; Serine; Threonine; White People | 2009 |
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.
Topics: Aged; Aged, 80 and over; Asparagine; Cell Line, Transformed; Female; Genetic Testing; Guanosine Triphosphate; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Norway; Parkinson Disease; Protein Serine-Threonine Kinases; Psychiatric Status Rating Scales; Tomography, Emission-Computed, Single-Photon; Transfection | 2010 |
First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.
Topics: Aged; alpha-Synuclein; Asparagine; Brain; DNA Mutational Analysis; DNA-Binding Proteins; Family Health; Female; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Magnetic Resonance Imaging; Male; Parkinson Disease; Protein Serine-Threonine Kinases; RNA-Binding Protein FUS; Ubiquitin | 2012 |
Vacuolar protein sorting 35 Asp620Asn mutation is rare in the ethnic Chinese population with Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Asparagine; Aspartic Acid; China; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins | 2012 |
VPS35 mutation in Japanese patients with typical Parkinson's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asian People; Asparagine; Aspartic Acid; Child; Disability Evaluation; Family Health; Female; Genetic Predisposition to Disease; Genetic Testing; Haplotypes; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins; Young Adult | 2012 |
VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China.
Topics: Adult; Aged; Arginine; Asparagine; Aspartic Acid; Case-Control Studies; China; Eukaryotic Initiation Factor-4G; Female; Histidine; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins; Young Adult | 2013 |
Tau gene delN296 mutation, Parkinson's disease, and atypical supranuclear palsy.
Topics: Adult; Asparagine; DNA Mutational Analysis; Exons; Family Health; Female; Gene Deletion; Genotype; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Supranuclear Palsy, Progressive; tau Proteins | 2004 |
Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene.
Topics: Asparagine; Humans; Mutation; Parkinson Disease; Supranuclear Palsy, Progressive; tau Proteins | 2004 |
Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.
Topics: Adult; Aged; Aged, 80 and over; Asparagine; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Glucosylceramidase; Heterozygote; Humans; Leucine; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Serine | 2006 |
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.
Topics: Adult; Aged; Aged, 80 and over; Asparagine; Autopsy; Brain; DNA Mutational Analysis; Female; Glucosylceramidase; Humans; Isoleucine; Lewy Body Disease; Male; Middle Aged; Mutation; Parkinson Disease; Risk Factors; Synucleins; Threonine | 2006 |
A novel LRRK2 mutation in an Austrian cohort of patients with Parkinson's disease.
Topics: Aged; Asparagine; Austria; Cohort Studies; DNA Mutational Analysis; Exons; Family Health; Female; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Serine | 2007 |
Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.
Topics: Aged; Asparagine; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glucosylceramidase; Humans; Italy; Leucine; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Serine | 2008 |
Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Topics: Aged; Asparagine; Case-Control Studies; DNA Mutational Analysis; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Glucosylceramidase; Humans; Leucine; Lewy Body Disease; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Risk Factors; Serine | 2008 |
Parkinson's disease and the heterozygous state for glucocerebrosidase mutations among Brazilians.
Topics: Adult; Asparagine; Brazil; Female; Glucosylceramidase; Heterozygote; Humans; Leucine; Male; Middle Aged; Mutation; Parkinson Disease; Proline; Serine | 2009 |
Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.
Topics: Aged; Amino Acids; Asparagine; Aspartic Acid; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glycine; Humans; Male; Middle Aged; Neurotransmitter Agents; Parkinson Disease | 1996 |
EEG depth leads during stereotaxic brain surgery. A report on 117 cases (5 target points, effects of 13 different drugs).
Topics: Amides; Amygdala; Antimetabolites; Asparagine; Benzoates; Brain; Brain Diseases; Cerebrovascular Circulation; Child; Chlordiazepoxide; Diazepam; Dihydroxyphenylalanine; Electroencephalography; Female; Fluphenazine; Gyrus Cinguli; Hippocampus; Humans; Hyperkinesis; Male; Methanol; Middle Aged; Parkinson Disease; Pyridines; Pyridoxine; Spasm; Stereotaxic Techniques; Thalamic Nuclei; Theophylline; Tranquilizing Agents; Triflupromazine; Vasodilator Agents | 1970 |